世界の核画像装置（医療機器）市場：企業動向...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
3 Competitive Assessment 9
3.1 Overview 9
3.2 Dedicated PET Systems 9
3.2.1 Overview 9
3.2.2 Product Profile 10
3.2.3 SWOT Analysis 11
3.3 PET/CT Systems 11
3.3.1 Overview 11
3.3.2 Product Profiles 12
3.3.3 SWOT Analysis 14
3.4 PET/MRI Systems 14
3.4.1 Overview 14
3.4.2 Product Profile 16
3.4.3 SWOT Analysis 17
3.5 Dedicated SPECT Systems 17
3.5.1 Overview 17
3.5.2 Product Profile 19
3.5.3 SWOT Analysis 20
3.6 SPECT/CT Systems 21
3.6.1 Overview 21
3.6.2 Product Profile 23
3.6.3 SWOT Analysis 24
3.7 PET/Ultrasound and SPECT/Ultrasound Systems 25
3.7.1 Overview 25
3.7.2 Product Profile 25
3.7.3 SWOT Analysis 26
4 Pipeline Assessment 27
4.1 Overview 27
4.2 Pipeline by Phases in Development 28
4.3 Product Profiles 28
4.3.1 Brain Biosciences CerePET 28
4.3.2 ECORAD Dual Modality Imager 30
4.3.3 FMI Technologies ScintiStar PET/CT 31
4.3.4 IntraMedical Imaging Marginator Beta Camera 33
4.3.5 INSERT SPECT/MRI 34
4.3.6 Nucare/Zecotek Photonics New Generation PET Scanning Device 37
4.3.7 Philips Healthcare PET Alpha Ring Detector 38
4.3.8 Photo Diagnostic Systems NeuroPET/CT 39
4.3.9 SynchroPET Breast PET/MRI 40
4.3.10 SynchroPET Wrist Scanner 41
4.3.11 SurgicEye SPECT Hybrid 42
5 Clinical Trials to Watch 44
5.1 Overview 44
5.2 Clinical Trial Profiles 44
6 Current and Future Players 47
6.1 Overview 47
6.2 Trends in Corporate Strategy 47
6.3 Company Profiles 48
6.3.1 DDD-Diagnostic 48
6.3.2 Digirad 50
6.3.3 GE Healthcare 54
6.3.4 GVI Medical Devices 59
6.3.5 Mediso Medical Imaging Systems 62
6.3.6 NeuroLogica 64
6.3.7 Neusoft Medical Systems 66
6.3.8 NuCare Medical Systems 69
6.3.9 Oncovision 71
6.3.10 Philips Healthcare 73
6.3.11 Shimadzu 80
6.3.12 Siemens Healthcare 85
6.3.13 SurgicEye 90
6.3.14 Toshiba Medical 93
6.3.15 Other Companies 98
7 Appendix 101
7.1 Abbreviations 101
7.2 Bibliography 105
7.3 Methodology 122
7.3.1 Overview 122
7.3.2 Coverage 122
7.3.3 Secondary Research 122
7.4 Physicians and Specialists Included in This Study 124
7.5 Primary Research 126
7.5.1 Primary Research – Key Opinion Leader Interviews 126
7.5.2 Expert Panel Validation 126
7.5.3 Stakeholder Survey 127
7.6 Forecasting Methodology 129
7.7 About the Authors 130
7.7.1 Andrew Thompson, PhD, Senior Analyst 130
7.7.2 Priya Radhakrishnan, MBA, Director, Medical Devices 130
7.7.3 Bonnie Bain, PhD, Global Head of Healthcare 131
7.8 About GlobalData 132
7.9 Disclaimer 132